CAMP FY 2017 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$366M+4.2% YoY

Gross Profit

$151M41.2% margin

Operating Income

$8M2.2% margin

Net Income

$17M4.5% margin

EPS (Diluted)

$0.46

Cash Flow

Operating Cash Flow

$67M

Free Cash Flow

$59M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$473M

Total Liabilities

$274M

Stockholders' Equity

$199M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$366M	$351M	+4.2%
Gross Profit	$151M	$143M	+5.3%
Operating Income	$8M	$1M	+493.2%
Net Income	$17M	-$7M	+332.4%